Death Halts 'Off-the-Shelf' CAR-T Trial; BP and CRC; Obesity Dulls Docetaxel?

(MedPage Today) — FDA placed a clinical hold on the phase I MELANI-01 trial of UCARTCS1A — an investigational “off-the-shelf” CAR T-cell therapy — after a multiple myeloma patient died from cardiac arrest following treatment at the highest…

Source link

Related posts

Quality of life in adolescents recovering from sports-related concussion or fracture


Very Sick Kids Face High Anxiety, Depression


2003 to 2014 Saw Incidence of Herpes Zoster Drop in Children


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World